|
CA3097737A1
|
|
Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
|
|
AU2018388577A1
|
|
Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
|
|
US2021069105A1
|
|
Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
|
|
CA3085941A1
|
|
Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
|
|
US2014271857A1
|
|
Benzonatate modified release solid tablets and capsules
|
|
WO2014159340A1
|
|
Benzonatate modified release solid tablets and capsules
|
|
US2014093578A1
|
|
Novel clonidine formulation
|
|
WO2015076821A1
|
|
Novel clonidine formulation
|
|
BR112015003120A2
|
|
methylphenidate extended-release chewable tablet and its use
|
|
US2013261152A1
|
|
Orally effective methylphenidate extended release powder and aqueous suspension product
|
|
WO2013119231A1
|
|
Abuse resistant opioid drug - ion exchange resin complexes having hybrid coatings
|
|
WO2012112140A1
|
|
Extended release powder and aqueous suspension comprising methylphenidate
|
|
WO2008042218A1
|
|
Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
|
|
CN101400343A
|
|
Modified release formulations containing drug-ion exchange resin complexes
|
